Coffee And Cancer: A Disaster

| July 16, 2018

article image
Does Coffee Coffee Cause Cancer? While this is not a dumb question, we as a society have made a real mess of the answer. Let’s start with the facts. Coffee does not cause cancer. How do we know? Scientists have been doing research on this very subject for a long time. Meta-studies looking at all the scientific literature up to date have clearly shown that not only there is no association between coffee-drinking and cancer, but there is actually a mild inverse correlation between drinking coffee and some type of cancer. In other words, not only does coffee not give you cancer, but it may mildly protect you from some types of cancer, such as breast and liver cancer.

Spotlight

eHealth Innovation @ UHN

Our team improves quality of life by being the go-to place for developing cool and intuitive self-care and remote monitoring technologies for people with chronic diseases. We attract multidisciplinary talents including engineers, software developers, designers, project managers, and researchers. Leveraging our clinical connections with healthcare organizations globally, we develop technologies from users’ perspective, and evaluate our technologies to collect real data to assess their effectiveness and foster changes to better healthcare delivery.

OTHER ARTICLES

Defense biotech research looks to eliminate bacteria causing traveler’s diarrhea, reduce jet lag duration

Article | April 9, 2020

World traveler‘s will rejoice at the idea of a seemingly magical device that would guarantee they never suffer from the all-too-familiar stomach issues that come from traveling internationally while reducing jet lag at the same time. But it’s not just privileged globetrotters that would benefit from a device that eliminates the bacteria associated with the so-called Montezuma’s Revenge. In 2016, more than 230,000 children around the world died from some of the same types of bacteria as those that cause traveler’s diarrhea, and the bacteria mainly come from unsafe “drinking water, poor sanitation and malnutrition,” according to Oxford University’s Our World In Data portal. On Monday, DARPA announced it was researching an “implantable or ingestible bioelectronic carrier” that would eliminate the five major bacteria associated with traveler’s diarrhea.

Read More

Biotech: Finding The DNA For Success

Article | April 3, 2020

The integration of artificial intelligence within life sciences is making drug discovery and development more innovative, less labor intensive and more cost-effective, says Deloitte’s annual global outlook. According to Deloitte’s 2020 Global Life Sciences Outlook, the biotech sector is at an inflection point. To prepare for the future and remain relevant in the ever-evolving business landscape, biopharma and medtech organizations will be looking for new ways to create value and new metrics to make sense of today’s wealth of data, the report overview says. As data-driven technologies provide biopharma and medtech organizations with treasure troves of information, and automation takes over some mundane tasks, new talent models are emerging based on purpose and meaning. The integration of artificial intelligence (AI) and machine learning approaches within life sciences is making drug discovery and development more innovative, time-effective and cost-effective, the Deloitte report states.

Read More

Wisconsin biotech companies could play key roles in long-term economic recovery from COVID-19 pandemic

Article | April 19, 2020

Whether it’s called a modern “Manhattan Project” or a medical moon shot, the concept of long-term economic recovery rests on how confident people are they won’t risk serious illness by venturing forth in public again. Wisconsin stands to be a significant part of such an undertaking, whatever it’s called. The shorter-term debate is well under way over the gradual lifting of COVID-19 emergency rules, such as the now-extended “safer-at-home” order in Wisconsin. At least a dozen states, including regional coalitions on the East and West coasts, are exploring next steps as they seek to balance responses to the virus with calls for reopening the economy, at least, in part. Wisconsin’s ability to shape longer-term responses will come from private and public resources, which range from companies engaged in production of diagnostics.

Read More

Translating Pharmacomicrobiomics: Three Actionable Challenges/Prospects in 2020

Article | February 24, 2020

The year 2020 marks a decade since the term pharmacomicrobiomics was coined (Rizkallah et al., 2010) to crystallize a century-old concept of mutual interactions between humans, drugs, and the microbial world. The human microbiome, with its immense metabolic potential that exceeds and expands the human metabolic capacities, has the ability to modulate pharmacotherapy by affecting both pharmacokinetics and pharmacodynamics of drug molecules:

Read More

Spotlight

eHealth Innovation @ UHN

Our team improves quality of life by being the go-to place for developing cool and intuitive self-care and remote monitoring technologies for people with chronic diseases. We attract multidisciplinary talents including engineers, software developers, designers, project managers, and researchers. Leveraging our clinical connections with healthcare organizations globally, we develop technologies from users’ perspective, and evaluate our technologies to collect real data to assess their effectiveness and foster changes to better healthcare delivery.

Events